Symbio Pharmaceuticals Limited (4582) Press Release
Summary of Consolidated Financial Statements for the Six Months ended June 30, 2026 [Japanese GAAP]
Earlier from Symbio Pharmaceuticals
- SymBio Pharmaceuticals: Summary of Financial Statements for the First Six Months of Fiscal Year Ending December 31, 2022 (Consolidated)
- SymBio Pharmaceuticals: Revision to Earnings Forecast for FY 2022